NCT01360944

Exploratory Study to Investigate Efficacy of LAS41004 in a Psoriasis Plaque Test

An Investigator-blind, Controlled Exploratory Study to Assess the Efficacy and Safety of Different Concentrations of Active Ingredients in the Project LAS 41004 Compared to a Bland Ointment and to Active Control in a Psoriasis- Plaque- Test

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 22 (actual)
• Sponsor: Almirall, S.A. · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The aim of the exploratory study is to compare the dose-related efficacy of LAS41004 in a Psoriasis Plaque Test (PPT).

Conditions

• Psoriasis

Interventions

Type	Name	Description
DRUG	LAS41004	once daily, topical, 100 microgram
DRUG	reference	once daily, 100 microgram

Timeline

• Start date: 2011-05-01
• Primary completion: 2011-06-01
• Completion: 2011-06-01
• First posted: 2011-05-26
• Last updated: 2015-06-08

Locations

1 site across 1 country: Germany